Pembrolizumab increases level of the patomorfologichesky full answer at patients with the threefold negative cancer of a mammary gland (TNCMG) at application in a combination with chemotherapy in a neoadjyuvantny mode

Show original
30.09.2019 – Company presented to MSD results of the research KEYNOTE-522 in which pembrolizumab it was applied in a neoadjyuvantnom/adjyuvantny mode at patients with early stages of the threefold negative cancer mammary gland (TNCMG)...

Full article is available at its source

Go to full article
Open the Connections Tree and see if United States of... and are connected in any way
Try it

Sign up for more features!

Get full access to news analytics for free and without ads.

Article analysis

in this article
Zakirova Lilia
in this article